Chaeum Premium 4 Dermal Fillers
High-purity monophasic hyaluronic acid filler with advanced Hylink™ cross-linking technology (23% cross-link ratio)
Medical Grade HA Formulation
Chaeum Premium utilizes patented Hylink™ cross-linking technology to create monodisperse HA molecules with uniform particle distribution (PDI <0.2). The 14-day dialysis process achieves BDDE residuals <0.5ppm and endotoxin levels <0.03 EU/ml, meeting ISO 10993 biocompatibility standards. Third-party testing confirms 99.8% purity with protein content <0.05% (w/w).
Clinical Advantages
Enhanced Safety Profile
14-day dialysis reduces BDDE residuals to <0.5ppm (vs industry standard 2ppm)
Optimal Viscosity
G prime of 350Pa ensures natural tissue integration with 92% patient satisfaction
Precision Delivery
Constant extrusion force (12N±0.5) enables smooth tissue distribution
Longevity
12-18 month duration confirmed in 83% of subjects (24-month follow-up)
Product Specifications
- Composition: HA 20 mg/ml + Lidocaine 0.3%
- Cross-linking: 23% (Hylink™ Technology)
- Needle: 23G×1/2″ (4 needles/pack)
- Volume: 2×1.1ml sterile syringes
- Storage: 2-25°C protected from light
- Shelf Life: 24 months unopened
Clinical Protocol
- Indication: Deep subcutaneous injection
- Areas: Cheeks, Chin, Temples (Zone 2-3)
- Technique: Linear threading or fanning
- Depth: 4-6mm below dermis
- Max Dose: 2.2ml per session
- Touch-up: ≥4 weeks interval
Application Guidelines
Midface Volumization
For cheek augmentation: Deposit 0.05-0.1ml aliquots in supraperiosteal plane using 23G cannula. Maximum 1.5ml per midface compartment.
Chin Enhancement
For chin projection: Retrograde linear threads in mentalis muscle (0.4-0.6ml). Use bony landmarks to avoid mental nerve injury.
Temporal Recontouring
Temporal fossa injection: 25G needle at 30° angle, 0.2ml per depot point. Maximum 1.0ml per temporal region.
Medical Notice
Important: Individual results may vary based on tissue characteristics and injection technique. Strict contraindications include: active skin infections, bleeding disorders, and hypersensitivity to lidocaine.
This product must be administered by licensed medical professionals with dermal filler certification. Post-treatment monitoring for vascular complications is mandatory. Product use constitutes acceptance of full procedural responsibility by administering practitioner.
